Japan "pioneering product" premium to encourage local development?
This article was originally published in Scrip
After lengthy debate, Japan has formally adopted a final set of drug pricing reforms for implementation at the time of the next regular biennial revision of reimbursement prices on 1 April.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.